SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 203 filers reported holding SEATTLE GENETICS INC in Q1 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $58,000 | -13.4% | 294 | -25.2% | 0.00% | – |
Q2 2020 | $67,000 | -36.8% | 393 | -57.4% | 0.00% | -100.0% |
Q1 2020 | $106,000 | +1.0% | 922 | 0.0% | 0.00% | – |
Q4 2019 | $105,000 | -20.5% | 922 | -77.6% | 0.00% | -100.0% |
Q4 2014 | $132,000 | +4300.0% | 4,115 | +4422.0% | 0.00% | – |
Q3 2014 | $3,000 | – | 91 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |